Chemical Name: (1S,2S,3S,5R)-5-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-((1S,2R)-2-(3,4-difluorophenyl)cyclopropoxy)-3-(2-hydroxyethoxy)cyclopentan-1-ol
Smiles: FC1=C(F)C=CC([C@@H]2[C@@H](O[C@@H]3[C@H](O)[C@@H](OCCO)C[C@H]3N4N=NC5=C4N=C(SCCC)N=C5N)C2)=C1
Inchi: InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26)18-22(28-23)31(30-29-18)15-10-17(34-6-5-32)20(19(15)33)35-16-9-12(16)11-3-4-13(24)14(25)8-11/h3-4,8,12,15-17,19-20,32-33H,2,5-7,9-10H2,1H3,(H2,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42